Skip to content

Discontinued — last reported Q4 '21

Operating margin at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
26.4%+2.8pp
Amgen logo
AmgenAMGN
28.4%+6.6pp
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
24.3%-2.9pp
Janux Therapeutics logo
Janux TherapeuticsJANX
-1,143.1%-65.1pp
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
-242%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
-185.4%-83.3pp

Other financials

Income statement

See full
Revenue-
Operating income-$53.7M+2.4%
Net income-$49.7M-2.4%
EPS (diluted)-$0.69+24.2%

Balance sheet

See full
Cash & equivalents$75.1M-2.1%
Total debt$2.4M+29.5%
Total equity$408.7M-30.8%
Total assets$403.0M-30.5%

Cash flow

See full
Operating cash flow-$46.0M-6.7%
CapEx$11.0K
Free cash flow-$38.1M-4.1%

Valuation

See full
Market cap$1.08B+140%
Enterprise value$1.01B+168%

Profitability

See full
Net margin-346.1%

Returns & leverage

See full
Return on equity-44%+26.2pp
Debt / equity0.0×
Current ratio10.3×-1.3×

Where this comes from

Calculated from Cullinan Therapeutics, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Cullinan Therapeutics, Inc.’s 10-K, filed March 9, 2023, on SEC EDGAR. View the filing →

Ask your AI about Cullinan Therapeutics, Inc.'s operating margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cullinan Therapeutics, Inc.'s operating margin?
Cullinan Therapeutics, Inc. (CGEM) reported operating margin of -358.7% in Q4 2021.
What does operating margin mean?
Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.